An adjuvant is a substance that is formulated as part of a vaccine to enhance its ability to induce protection against infection.
The report focuses on the Vaccine Adjuvants market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Vaccine Adjuvants market.
Major Players in the Vaccine Adjuvants market are:
OZ Biosciences
Avanti Polar Lipids, Inc.
SPI Pharma, Inc.
CSL Limited
Brenntag Biosector
Vaxine Pty Ltd
VaxLiant LLC.
Aphios Corporation
Novavax, Inc.
CureVac AG
Adjuvatis
Viscogel AB
MPV Technologies
Invivogen
SEPPIC
Agenus, Inc.
Sigma-Aldrich Co. LLC
Sergeant Adjuvants
On the basis of types, the Vaccine Adjuvants market is primarily split into:
Pathogen Components
Adjuvant Emulsions
Particulate Adjuvants
Combination Adjuvants
Others
On the basis of applications, the market covers:
Pharmaceutical Companies
Research Institutes
Contract Manufacturing Organization
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Vaccine Adjuvants Market Research Report 2022 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2029
Chapter 1 Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Vaccine Adjuvants
1.2 Vaccine Adjuvants Market Segmentation by Type
1.2.1 Global Production Market Share of Vaccine Adjuvants by Type in 2020
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Vaccine Adjuvants Market Segmentation by Application
1.3.1 Vaccine Adjuvants Consumption Market Share by Application in 2020
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Vaccine Adjuvants Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Vaccine Adjuvants (2014-2029)
Chapter 2 Global Economic Impact on Vaccine Adjuvants Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Vaccine Adjuvants Market Competition by Manufacturers
3.1 Global Vaccine Adjuvants Production and Share by Manufacturers (2020 and 2022)
3.2 Global Vaccine Adjuvants Revenue and Share by Manufacturers (2020 and 2022)
3.3 Global Vaccine Adjuvants Average Price by Manufacturers (2020 and 2022)
3.4 Manufacturers Vaccine Adjuvants Manufacturing Base Distribution, Production Area and Product Type
3.5 Vaccine Adjuvants Market Competitive Situation and Trends
3.5.1 Vaccine Adjuvants Market Concentration Rate
3.5.2 Vaccine Adjuvants Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Vaccine Adjuvants Production, Revenue (Value) by Region (2014-2022)
4.1 Global Vaccine Adjuvants Production by Region (2014-2022)
4.2 Global Vaccine Adjuvants Production Market Share by Region (2014-2022)
4.3 Global Vaccine Adjuvants Revenue (Value) and Market Share by Region (2014-2022)
4.4 Global Vaccine Adjuvants Production, Revenue, Price and Gross Margin (2014-2022)
4.5 North America Vaccine Adjuvants Production, Revenue, Price and Gross Margin (2014-2022)
4.6 Europe Vaccine Adjuvants Production, Revenue, Price and Gross Margin (2014-2022)
4.7 China Vaccine Adjuvants Production, Revenue, Price and Gross Margin (2014-2022)
4.8 Japan Vaccine Adjuvants Production, Revenue, Price and Gross Margin (2014-2022)
4.9 Southeast Asia Vaccine Adjuvants Production, Revenue, Price and Gross Margin (2014-2022)
4.10 India Vaccine Adjuvants Production, Revenue, Price and Gross Margin (2014-2022)
Chapter 5 Global Vaccine Adjuvants Supply (Production), Consumption, Export, Import by Regions (2014-2022)
5.1 Global Vaccine Adjuvants Consumption by Regions (2014-2022)
5.2 North America Vaccine Adjuvants Production, Consumption, Export, Import by Regions (2014-2022)
5.3 Europe Vaccine Adjuvants Production, Consumption, Export, Import by Regions (2014-2022)
5.4 China Vaccine Adjuvants Production, Consumption, Export, Import by Regions (2014-2022)
5.5 Japan Vaccine Adjuvants Production, Consumption, Export, Import by Regions (2014-2022)
5.6 Southeast Asia Vaccine Adjuvants Production, Consumption, Export, Import by Regions (2014-2022)
5.7 India Vaccine Adjuvants Production, Consumption, Export, Import by Regions (2014-2022)
Chapter 6 Global Vaccine Adjuvants Production, Revenue (Value), Price Trend by Type
6.1 Global Vaccine Adjuvants Production and Market Share by Type (2014-2022)
6.2 Global Vaccine Adjuvants Revenue and Market Share by Type (2014-2022)
6.3 Global Vaccine Adjuvants Price by Type (2014-2022)
6.4 Global Vaccine Adjuvants Production Growth by Type (2014-2022)
Chapter 7 Global Vaccine Adjuvants Market Analysis by Application
7.1 Global Vaccine Adjuvants Consumption and Market Share by Application (2014-2022)
7.2 Global Vaccine Adjuvants Consumption Growth Rate by Application (2014-2022)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Vaccine Adjuvants Manufacturing Cost Analysis
8.1 Vaccine Adjuvants Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Vaccine Adjuvants
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Vaccine Adjuvants Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Vaccine Adjuvants Major Manufacturers in 2020
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Vaccine Adjuvants Market Forecast (2022-2029)
12.1 Global Vaccine Adjuvants Production, Revenue Forecast (2022-2029)
12.2 Global Vaccine Adjuvants Production, Consumption Forecast by Regions (2022-2029)
12.3 Global Vaccine Adjuvants Production Forecast by Type (2022-2029)
12.4 Global Vaccine Adjuvants Consumption Forecast by Application (2022-2029)
12.5 Vaccine Adjuvants Price Forecast (2022-2029)
Chapter 13 Appendix